Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPotential Vitamin-Drug Interactions in Children: At a Pediatric Emergency Department
Pediatric Drugs, 07/29/09
Goldman RD et al. – Taking into account the high rate of potential vitamin–drug interactions, especially among older children and patients with chronic illness, parents and healthcare providers need to balance the potential benefit of concurrent vitamin–medication use with its potential harms.
Related Articles
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09
Relevance Score: 72%
Quantitative prediction and clinical observation of a cyp3a inhibitor-based drug-drug interactions with mln3897, a potent ccr1 antagonist
Journal of Pharmacology and Experimental Therapeutics, 11/12/09
Relevance Score: 69%
Prediction of Human Drug and Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator
Drug Metabolism and Disposition, 10/06/09
Relevance Score: 69%
Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells
Transplantation Proceedings, 11/13/09
Relevance Score: 68%
Clinically Significant Adverse Events from a Drug Interaction Between Quetiapine and Atazanavir-Ritonavir in Two Patients
Pharmacotherapy, 10/27/09
Relevance Score: 68%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide
Clinical Therapeutics, 12/01/09
Sponsor
Article Search
Sponsor